心脏导管室中的低分子量肝素。 - Suppr

Suppr

超能文献

Low molecular weight heparins in the cardiac catheterization laboratory.

作者信息

Montalescot G, Cohen M

机构信息

Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.

出版信息

J Thromb Thrombolysis. 1999 Jun;7(3):319-23. doi: 10.1023/a:1008943529597.

DOI:10.1023/a:1008943529597

PMID:10373715

Abstract

摘要

相似文献

Low molecular weight heparins in the cardiac catheterization laboratory.

J Thromb Thrombolysis. 1999 Jun;7(3):319-23. doi: 10.1023/a:1008943529597.

Evolution of improved antithrombotic and antiplatelet agents: genesis of the Comparison of Abciximab Complications with Hirulog [and back-Up Abciximab] Events Trial (CACHET).

Am J Cardiol. 1998 Oct 22;82(8B):63P-68P. doi: 10.1016/s0002-9149(98)00664-x.

Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment.

Can J Cardiol. 2006 May 1;22(6):511-5. doi: 10.1016/s0828-282x(06)70271-9.

Vascular drugs in the new millennium.

J Am Coll Surg. 2000 Jul;191(1):76-92. doi: 10.1016/s1072-7515(00)00292-1.

[Optimal platelet inhibition therapy in unstable angina pectoris and after coronary interventions].

Herz. 2001 Apr;26 Suppl 1:36-41. doi: 10.1007/pl00014030.

Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.

J Invasive Cardiol. 2002 Dec;14 Suppl E:27E-34E; quiz 35E.

Antithrombotic therapy of unstable angina and non-Q-wave myocardial infarction.

Int J Cardiol. 1999 Apr 10;68 Suppl 1:S63-71. doi: 10.1016/s0167-5273(98)00293-9.

The emerging role of low-molecular-weight heparin and antiplatelet therapies in the cardiac catheterization laboratory.

Am Heart J. 1999 Dec;138(6 Pt 2):S577-85. doi: 10.1053/hj.1999.v138.a102299.

New antiplatelet agents.

Aust N Z J Med. 1998 Aug;28(4):558-64. doi: 10.1111/j.1445-5994.1998.tb02111.x.

[Antithrombotic therapy during percutaneous coronary interventions].

Ned Tijdschr Geneeskd. 2005 Apr 23;149(17):912-6.

引用本文的文献

Unfractionated versus fractionated heparin for percutaneous coronary intervention.

Curr Cardiol Rep. 2002 Jul;4(4):327-33. doi: 10.1007/s11886-002-0069-6.

本文引用的文献

Increased platelet responsiveness following coronary stenting. Heparin as a possible aetiological factor in stent thrombosis.

Eur Heart J. 1998 Aug;19(8):1239-48. doi: 10.1053/euhj.1998.1047.

Low-molecular-weight heparins in coronary stenting (the ENTICES trial). ENoxaparin and TIClopidine after Elective Stenting.

Am J Cardiol. 1998 Sep 10;82(5B):29L-32L. doi: 10.1016/s0002-9149(98)00110-6.

Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.

Circulation. 1998 Jul 28;98(4):294-9. doi: 10.1161/01.cir.98.4.294.

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

Lancet. 1998 Jul 11;352(9122):87-92. doi: 10.1016/s0140-6736(98)06113-3.

Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators.

Circulation. 1998 Mar 10;97(9):857-64. doi: 10.1161/01.cir.97.9.857.

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.

Circulation. 1998 Jan 27;97(3):251-6. doi: 10.1161/01.cir.97.3.251.

Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators.

J Am Coll Cardiol. 1998 Jan;31(1):23-30. doi: 10.1016/s0735-1097(97)00439-7.

Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale.

Circulation. 1997 Nov 18;96(10):3396-402. doi: 10.1161/01.cir.96.10.3396.

Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.

N Engl J Med. 1997 Sep 11;337(11):740-7. doi: 10.1056/NEJM199709113371103.

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

N Engl J Med. 1997 Aug 14;337(7):447-52. doi: 10.1056/NEJM199708143370702.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验